Market Overview

Endo Health Solutions to Buy Boca Pharmacal for $225M

Share:
Related ENDP
FTC Keeps Pressure On Wall Street, Refiles Suit Against Allergan, Others
The Market In 5 Minutes: Trump Inauguration Takes Center Stage
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2016 Update (Seeking Alpha)

Endo Health Solutions (NASDAQ: ENDP) today announced that its Qualitest subsidiary has reached a definitive agreement to acquire privately held Boca Pharmacal, a specialty generics company, for $225 million in cash.  The transaction is expected to enhance the growth platform and pipeline for Endo's Qualitest business and is consistent with Endo's strategic transformation into a leading specialty healthcare company.

Posted-In: News M&A

 

Related Articles (ENDP)

View Comments and Join the Discussion!